Product
AstroStem
1 clinical trial
1 indication
Indication
Alzheimer's diseaseClinical trial
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of AstroStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells, in Patients With Alzheimer's DiseaseStatus: Not yet recruiting, Estimated PCD: 2024-05-30